Cargando…

Appropriate use of cancer comprehensive genome profiling assay using circulating tumor DNA

Comprehensive genomic profiling (CGP) is being increasingly used for the routine clinical management of solid cancers. In July 2018, the use of tumor tissue‐based CGP assays became available for all solid cancers under the universal health insurance system in Japan. Several restrictions presently ex...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sunami, Kuniko, Bando, Hideaki, Yatabe, Yasushi, Naito, Yoichi, Takahashi, Hideaki, Tsuchihara, Katsuya, Toyooka, Shinichi, Mimori, Koshi, Kohsaka, Shinji, Uetake, Hiroyuki, Kinoshita, Ichiro, Komine, Keigo, Takeda, Masayuki, Hayashida, Tetsu, Tamura, Kenji, Nishio, Kazuto, Yamamoto, Noboru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409307/ https://www.ncbi.nlm.nih.gov/pubmed/34128569 http://dx.doi.org/10.1111/cas.15022

Ejemplares similares

Clinical practice guidance for next-generation sequencing in cancer diagnosis and treatment (edition 2.1)
por: Naito, Yoichi, et al.
Publicado: (2020)

Expert panel consensus recommendations on the use of circulating tumor DNA assays for patients with advanced solid tumors
por: Imai, Mitsuho, et al.
Publicado: (2022)

The initial assessment of expert panel performance in core hospitals for cancer genomic medicine in Japan
por: Sunami, Kuniko, et al.
Publicado: (2021)

Chronological improvement in precision oncology implementation in Japan
por: Sunami, Kuniko, et al.
Publicado: (2022)

Concordance Between Recommendations From Multidisciplinary Molecular Tumor Boards and Central Consensus for Cancer Treatment in Japan
por: Naito, Yoichi, et al.
Publicado: (2022)

A Learning Program for Treatment Recommendations by Molecular Tumor Boards and Artificial Intelligence
por: Sunami, Kuniko, et al.
Publicado: (2023)

Clinical practice guidance for next‐generation sequencing in cancer diagnosis and treatment (Edition 1.0)
por: Sunami, Kuniko, et al.
Publicado: (2018)

SCRUM‐Japan GI‐SCREEN and MONSTAR‐SCREEN: Path to the realization of biomarker‐guided precision oncology in advanced solid tumors
por: Nakamura, Yoshiaki, et al.
Publicado: (2021)

Recommendations related to the analytical equivalence assessment of gene panel testing
por: Nagai, Sumimasa, et al.
Publicado: (2022)

Phase I dose‐escalation study of capmatinib (INC280) in Japanese patients with advanced solid tumors
por: Esaki, Taito, et al.
Publicado: (2019)

Simultaneous identification of 36 mutations in KRAS codons 61and 146, BRAF, NRAS, and PIK3CA in a single reaction by multiplex assay kit
por: Bando, Hideaki, et al.
Publicado: (2013)

Comparative sequence analysis of patient-matched primary colorectal cancer, metastatic, and recurrent metastatic tumors after adjuvant FOLFOX chemotherapy
por: Harada, Kazuaki, et al.
Publicado: (2019)

A computational tool to detect DNA alterations tailored to formalin-fixed paraffin-embedded samples in cancer clinical sequencing
por: Kato, Mamoru, et al.
Publicado: (2018)

Feasibility study of cancer genome alterations identified by next generation sequencing: ABC study
por: Naito, Yoichi, et al.
Publicado: (2018)

Novel and classic approaches for managing gastrointestinal cancers
por: Mimori, Koshi
Publicado: (2023)

Calcifying aponeurotic fibroma of the finger in an elderly patient: CT and MRI findings with pathologic correlation
por: NISHIO, JUN, et al.
Publicado: (2014)

Curcumin β-D-Glucuronide Modulates an Autoimmune Model of Multiple Sclerosis with Altered Gut Microbiota in the Ileum and Feces
por: Khadka, Sundar, et al.
Publicado: (2021)

Corrigendum: Curcumin β-D-Glucuronide Modulates an Autoimmune Model of Multiple Sclerosis with Altered Gut Microbiota in the Ileum and Feces
por: Khadka, Sundar, et al.
Publicado: (2022)

Identification of appropriate cone length to avoid positive cone margin in high grade cervical intraepithelial neoplasia
por: Kawano, Kouichiro, et al.
Publicado: (2016)

PEDT-12 NATIONWIDE LANDSCAPE OF GENOMIC ANALYSIS OF PEDIATRIC CENTRAL NERVOUS SYSTEM TUMORS
por: Watanabe, Yuko, et al.
Publicado: (2022)

Precision Oncology and the Universal Health Coverage System in Japan
por: Ebi, Hiromichi, et al.
Publicado: (2019)

Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumors
por: Naito, Yoichi, et al.
Publicado: (2023)

Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of immunotherapy in patients with DNA mismatch repair deficient (dMMR) tumors, third edition
por: Mishima, Saori, et al.
Publicado: (2023)

Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of immunotherapy in patients with high tumor mutational burden tumors
por: Mishima, Saori, et al.
Publicado: (2023)

Effect of food on the pharmacokinetics of TAS‐102 and its efficacy and safety in patients with advanced solid tumors
por: Yoshino, Takayuki, et al.
Publicado: (2016)

Phase 1 study of napabucasin, a cancer stemness inhibitor, in patients with advanced solid tumors
por: Kawazoe, Akihito, et al.
Publicado: (2020)

Reply: KRAS mutation in colorectal cancer metastases after adjuvant folfox for the primary
por: Yoshino, T, et al.
Publicado: (2012)

Artificial intelligence-assisted drug repurposing via “chemical-induced gene expression ranking”
por: Masuda, Takaaki, et al.
Publicado: (2022)

Japanese Society of Medical Oncology Clinical Guidelines: RAS (KRAS/NRAS) mutation testing in colorectal cancer patients11
por: Taniguchi, Hiroya, et al.
Publicado: (2015)

Real‐world study of next‐generation sequencing diagnostic biomarker testing for patients with lung cancer in Japan
por: Takahashi, Toshiaki, et al.
Publicado: (2023)

Sjögren's Syndrome as an Immune-related Adverse Event of Nivolumab Treatment for Gastric Cancer
por: Higashi, Tetsuo, et al.
Publicado: (2020)

Appropriateness rating for the application of optimal medical therapy and multidisciplinary care among heart failure patients
por: Shoji, Satoshi, et al.
Publicado: (2020)

Mucoepidermoid carcinoma cured by a combination of high‐frequency snare and photodynamic therapy: A case report
por: Tamura, Kentaro, et al.
Publicado: (2023)

Phase I study of the irreversible fibroblast growth factor receptor 1–4 inhibitor futibatinib in Japanese patients with advanced solid tumors
por: Doi, Toshihiko, et al.
Publicado: (2022)

Clonal Hematopoiesis From Next Generation Sequencing of Plasma From a Patient With Lung Adenocarcinoma: A Case Report
por: Ito, Munehiro, et al.
Publicado: (2020)

EVI1 exerts distinct roles in AML via ERG and cyclin D1 promoting a chemoresistant and immune-suppressive environment
por: Masamoto, Yosuke, et al.
Publicado: (2022)

Japanese Society of Medical Oncology Clinical Guidelines: Molecular Testing for Colorectal Cancer Treatment, Third Edition
por: Yamazaki, Kentaro, et al.
Publicado: (2018)

Reversal of Cisplatin Resistance by the 1,4‐Benzothiazepine Derivative, JTV‐519
por: Nakamura, Takashi, et al.
Publicado: (2001)

The Clinical Landscape of Circulating Tumor DNA in Gastrointestinal Malignancies
por: Sawada, Kentaro, et al.
Publicado: (2018)

Appropriate Antibiotic Selection during the in-hospital Waiting Period for Surgery for Appendicitis
por: Yukumi, Shungo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f0q0p6chqslclgkkeav63p6uq3